Bronchitol Resubmitted to Australian Pharmaceuticals Benefits Advisory Committee
12th
Jul 11
Release Date: 12/07/2011 12:00am
Pharmaxis today announced that it has resubmitted an application for its cystic fibrosis product Bronchitol to the Pharmaceutical Benefits Advisory Committee for reimbursement on the Australian Pharmaceutical Benefits Scheme.
Categories: News and Media